LBH589

Novartis bone marrow drug improves progression-free survival
Yahoo/Reuters
Mon, 06/2/14 - 10:04 am
Novartis
LBH589
Multiple Myeloma
ASCO
Novartis bone marrow cancer drug meets goal in late-stage study
Yahoo/AP
Fri, 12/6/13 - 09:01 am
Novartis
LBH589
Multiple Myeloma
Merck, Novartis Blood Cancer Drugs May Shrink Child Tumors, Study Finds
Bloomberg
Wed, 03/30/11 - 12:44 pm
Novartis
Merck
HDAC inhibitors
LBH589
Zolinza